Guardant Health (GH) Stock Highlights

31.67 | +1.73%

2024-12-21 02:47:23

Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The companys pipeline includes Guardant Reveal (formerly Lunar-1), for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. The United States accounts for 90% of total revenue, and other markets the remaining 10%.

Statistics

Range Today

30.49 32.22

Volume Today 2.41M

Range 1 Year

15.81 38.53

Volume 1 Year 504.71M

Range 3 Year

15.81 103.16

Volume 3 Year 1.28B

Range 10 Year

15.81 181.07

Volume 10 Year 2.1B

Highlights

Market Capitalization 3.53B (mid)

Floating Shares 111.26M

Current Price 31.67

Price To Earnings -6.68

Price To Revenue 5.55

Earnings Per Share -4.28

Payout Ratio 0%

Performance

Latest +1.73%

1 Month +3.29%

3 Months +24.73%

6 Months +6.45%

1 Year +22.75%

3 Years -68.72%

5 Years -61.34%

10 Years +14.13%

Benchmarks

Market Capitalization

26 / 58

Gross Profits

26 / 52

Total Revenue

28 / 57

Total Rank

46 / 58

Free Cashflow

53 / 56

Performance 5 years

40 / 58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.